
ADXS
Healthcare · Biotechnology · $1.7M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jan 31, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 25, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 28, 2025 | Time not confirmed | — | 0.00 | — |
| Aug 29, 2025 | Time not confirmed | — | 0.00 | — |
| May 30, 2025 | Time not confirmed | — | 0.00 | — |
| Feb 26, 2025 | Time not confirmed | — | 0.00 | — |
| Nov 29, 2024 | Time not confirmed | — | 0.00 | — |
| Aug 9, 2024 | Time not confirmed | — | 0.00 | — |
| Apr 16, 2024 | After the close | -1.27 | -2.96 | -133.1% |
| Nov 20, 2023 | Before the open | -1.28 | 0.00 | +100.0% |
| Sep 11, 2023 | After the close | -1.53 | -1.82 | -19.0% |
| Aug 10, 2023 | Time not confirmed | -1.32 | -1.82 | -37.9% |
| Jun 6, 2023 | Before the open | -2.19 | -2.19 | 0.0% |
| Feb 10, 2023 | Before the open | -0.73 | -2.53 | -246.6% |
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers in Israel and the United States. The company is developing AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in…
| Dec 28, 2022 | Time not confirmed | -0.73 | -2.53 | -246.6% |
| Sep 13, 2022 | Before the open | -0.04 | -3.83 | -9475.0% |
| Jun 8, 2022 | Before the open | -0.04 | -1.90 | -4650.0% |
| Mar 17, 2022 | Before the open | -3.20 | -3.20 | 0.0% |
| Sep 10, 2021 | Before the open | -3.20 | -1.60 | +50.0% |
| Jun 14, 2021 | After the close | -4.00 | -3.20 | +20.0% |
| Mar 16, 2021 | Before the open | -0.15 | -0.05 | +66.7% |
| Jan 22, 2021 | After the close | -0.15 | -7.37 | -4813.3% |
| Sep 10, 2020 | Before the open | -12.00 | -7.20 | +40.0% |
| Jun 11, 2020 | Before the open | -12.00 | -8.00 | +33.3% |
| Mar 13, 2020 | Before the open | -15.20 | -12.00 | +21.1% |
| Dec 20, 2019 | Before the open | -24.80 | -12.00 | +51.6% |
| Sep 9, 2019 | Before the open | -105.60 | -80.00 | +24.2% |
| Jun 10, 2019 | After the close | -96.00 | -105.60 | -10.0% |
| Mar 12, 2019 | Before the open | -300.00 | 216.00 | +172.0% |
| Jan 10, 2019 | After the close | -176.00 | -348.00 | -97.7% |
| Sep 10, 2018 | After the close | -300.00 | -324.00 | -8.0% |
| Jun 7, 2018 | Before the open | -516.00 | -324.00 | +37.2% |
| Mar 12, 2018 | After the close | -660.00 | -588.00 | +10.9% |